Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Nephritic factors predispose to chronic glomerulonephritis.

West CD.

Am J Kidney Dis. 1994 Dec;24(6):956-63. Review.

PMID:
7985676
4.
5.

The alternative pathway C3 convertase and glomerular deposits.

West CD, McAdams AJ.

Pediatr Nephrol. 1999 Jun;13(5):448-53. Review.

PMID:
10412868
6.

A C3 convertase assay for nephritic factor functional activity.

Jelezarova E, Schlumberger M, Sadallah S, Späth PJ, Schifferli JA, Lutz HU.

J Immunol Methods. 2001 May 1;251(1-2):45-52.

PMID:
11292480
7.

Anti-factor B autoantibody in dense deposit disease.

Strobel S, Zimmering M, Papp K, Prechl J, Józsi M.

Mol Immunol. 2010 Apr;47(7-8):1476-83. doi: 10.1016/j.molimm.2010.02.002. Epub 2010 Mar 1.

PMID:
20193965
8.

Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.

Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.

J Pediatr. 1990 May;116(5):S98-102.

PMID:
2329415
9.

A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.

Waldo FB, Forristal J, Beischel L, West CD.

J Clin Invest. 1985 Jun;75(6):1786-95.

10.

A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.

Clardy CW, Forristal J, Strife CF, West CD.

Clin Immunol Immunopathol. 1989 Mar;50(3):333-47.

PMID:
2917424
11.
12.
13.

An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis.

Marder HK, Coleman TH, Forristal J, Beischel L, West CD.

Kidney Int. 1983 May;23(5):749-58.

14.

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Licht C, Fremeaux-Bacchi V.

Thromb Haemost. 2009 Feb;101(2):271-8. Review.

PMID:
19190809
15.

Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.

Varade WS, Forristal J, West CD.

Am J Kidney Dis. 1990 Sep;16(3):196-206.

PMID:
2205097
16.

Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.

Tanuma Y, Ohi H, Hatano M.

Clin Immunol Immunopathol. 1990 Aug;56(2):226-38.

PMID:
2143128
17.

Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.

Meri S, Koistinen V, Miettinen A, Törnroth T, Seppälä IJ.

J Exp Med. 1992 Apr 1;175(4):939-50.

18.

Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.

Servais A, Noël LH, Dragon-Durey MA, Gübler MC, Rémy P, Buob D, Cordonnier C, Makdassi R, Jaber W, Boulanger E, Lesavre P, Frémeaux-Bacchi V.

Hum Pathol. 2011 Sep;42(9):1305-11. doi: 10.1016/j.humpath.2010.11.023. Epub 2011 Mar 10.

PMID:
21396679
19.

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M.

Nat Genet. 2002 Aug;31(4):424-8. Epub 2002 Jul 1.

PMID:
12091909
20.

Supplemental Content

Support Center